Recognizing #BreastCancerAwarenessMonth this October. We honor all those who have been impacted by breast cancer and support all efforts to educate and spread awareness of this disease this month and beyond.
Foundation Medicine
Biotechnology Research
Boston, Massachusetts 80,995 followers
Find Answers. Take Action. #WeAreFMI
About us
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter. Community Guidelines: bit.ly/FMICommunityGuidelines
- Website
-
http://www.foundationmedicine.com
External link for Foundation Medicine
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2010
- Specialties
- molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology
Locations
-
Primary
400 Summer St
Boston, Massachusetts 02210, US
-
7010 Kit Creek Road
Morrisville, NC 27560, US
Employees at Foundation Medicine
-
Michael Travers
Hello
-
Kathleen Gammon
AI savvy Release Manager & Scrum Master at Foundation Medicine
-
Allan Mohess
VP, Commercial Operations | Commercial Excellence and Sales Operations in Biotech, Healthcare & Software | Drives Growth through Strategic Business…
-
John Breen
Associate Director, R&D Automation Engineering and LIMS at Foundation Medicine
Updates
-
Join us and Precision Medicine Online next week for a live webinar on circulating tumor DNA (ctDNA) monitoring. Speakers will discuss ctDNA monitoring applications, case studies on ctDNA’s impact in clinical trials & more – click here to register: http://spkl.io/6042fMya8
-
New Pioneers in Practice webinar! In recognition of breast cancer awareness month, our programming will feature sessions on the value of comprehensive genomic profiling (CGP) in advanced breast cancer. Learn from experts as they share information on somatic versus germline alterations, biomarker testing guidelines, how to optimize the use of liquid biopsy and why PTEN matters in the treatment of advanced breast cancer. View our full schedule of October programming and registration information here: http://spkl.io/6046fzoZM
-
Given the diverse and complex nature of disease, treatment for patients with advanced #prostatecancer cannot be a “one-size-fits-all” approach. However, progress in research, advancements in biomarker testing and new targeted treatments are shifting the way that prostate cancer is treated towards more personalized options of care. Hear more from Chief Medical Officer, Dr. Mia Levy, in our latest #blog: http://spkl.io/6045fz9gc
-
Members of our team joined the National Ovarian Cancer Coalition (NOCC) at their annual Together in TEAL event in Boston last weekend. We’re honored to have been part of this event and are proud to support NOCC in raising awareness and education around #OvarianCancer
-
As a medical science liaison, Henry uses his cancer biology training to combine science with education to help further inform healthcare providers and our partners. Hear more about the impact the Medical Affairs team has on cancer research and view critical open roles on the team: http://spkl.io/6042fJQyk #WeAreFMI
-
Miss one of our NEW “Pioneers in Practice” educational webinars? In case you missed any featured sessions on the value of comprehensive genomic profiling (CGP) in advanced prostate cancer, we are thrilled to make these webinars available for your on-demand viewing. Click the link below to view all of our September webinars: http://spkl.io/6041fJQrX
-
Goodbye, summer! We closed out the season with in-person events at our Boston and Research Triangle Park locations, with our teams coming together to enjoy an afternoon of food, drinks and music. Looking forward to a great Fall ahead! #WeAreFMI
-
We are honored to continue our relationship with the U.S. Department of Veterans Affairs, National Precision Oncology Program, to provide Veterans with high-quality tumor molecular profiling tests and services. Our high-quality diagnostic tests being provided to the VA accurately identify the genomic mutations driving a patient’s cancer and match a patient to the most effective treatment options, including targeted therapies, immunotherapies or clinical trials. Read more here: http://spkl.io/6045fJlUv
-
Proud to share new research this World Cancer Research Day: A study in metastatic #prostatecancer showed that patients who have BRCA alterations, particularly homozygous loss of BRCA1/2, were more likely to have favorable outcomes and durable benefits from treatment with PARPi therapy as compared to other biomarker-specific groups. Patients analyzed were grouped based on specific HRR alteration status or Foundation Medicine’s HRD signature (HRDsig). Explore this research further in our latest research spotlight at the link here: http://spkl.io/6042fJYpe